BELLUS HEALTH COUGH INC has a total of 12 patent applications. Its first patent ever was published in 2018. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Australia. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are PHIVCO 1 LLC, WORLD TRADE IMP EXP WTIE AG and MYOVANT SCIENCES GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | United States | 2 | |
#3 | Australia | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Garceau Denis | 12 |
#2 | Chauret Nathalie | 11 |
#3 | Matzouranis Antonios | 11 |
#4 | Payza Kemal | 10 |
#5 | Bellini Roberto | 10 |
#6 | Browne Susan E | 7 |
#7 | Browne Susan | 2 |
#8 | Wenslow Robert | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020174283A1 | Treatment with p2x3 modulators | |
WO2020099923A1 | Crystalline forms of a substituted imidazopyridine compound and use thereof as p2x3 modulator | |
WO2020074962A1 | Treatment of pruritus with p2x3 antagonists | |
CN111601601A | Selective P2X3 modulators |